IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 25 filers reported holding IMMUNOVANT INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,235,000 | -96.6% | 77,000 | -90.2% | 0.02% | -96.9% |
| Q4 2020 | $36,197,000 | +24.7% | 783,651 | -5.0% | 0.58% | -1.8% |
| Q3 2020 | $29,021,000 | +36.9% | 824,705 | -5.3% | 0.60% | +15.5% |
| Q2 2020 | $21,199,000 | +123.5% | 870,604 | +42.9% | 0.52% | +62.8% |
| Q1 2020 | $9,485,000 | -3.7% | 609,399 | -1.9% | 0.32% | +21.0% |
| Q4 2019 | $9,851,000 | – | 621,505 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |